Positive control | Advantages | Disadvantages | Reference | |
---|---|---|---|---|
Uni-Control Method | • Can be used in the absence of wild-type control material | • Qualitative only not quantitative | Whiley et al., 2010 | |
• Reduced contamination | • Cannot be used for low viral loads | |||
• DNA and RNA compatible | • Greater risk of primer dimer formation | |||
• Quick and simple method | • Interim solution until wild-type material is available | |||
• Does not account for sequence variation in clinical material | ||||
Synthetic Controls | • DNA and RNA compatible | • Synthetic oligonucleotides must be less than 200 bp | Smith et al., 2006 | |
(Oligonucleotides and/or Plasmids) | • Reduced contamination (does not require cloning) | • Can be expensive if target is large | ||
• Production of a synthetic oligonucleotide and clone into a plasmid | • Target sequence must be known | |||
• No possibility of producing false-positives | • Requires two separate control reactions (primer and probe) | |||
• Can be used for rtPCR and conventional PCR | ||||
Cloned Plasmids | Imported | • Pre-made available (other labs or PlasmID repository) | • Requires shipping | None |
• Difficult to distinguish contamination from clinical material | ||||
• Cost effective | ||||
• Can be quantitative and qualitative | • Possible contamination | |||
Produced “in-house” | • Can be quantitative and qualitative | • Requires clinical material or live virus | None | |
• Cost effective | • Requires cloning (time consuming) | |||
• Can easily be produced | • Difficult to distinguish contamination from clinical material | |||
• Possible contamination |